[heparin and @entity2690 treatment of @entity656 caused by XXXX . Experience of 5 cases].

@entity2298 @entity1 @entity788 @entity656 @entity39 @entity1674 @entity2690 @entity1003 @entity412 @entity413
BACKGROUND: @entity2298 over 1,000 mg/dl can provoke @entity656 and its persistence can worsen the clinical outcome. On the contrary, a rapid decrease in @entity412 level is beneficial. Plasmapheresis has been performed in some @entity1 to remove chylomicrons from the circulation, while heparin and/or @entity2690 have been administered in some other cases to rapidly reduce blood @entity1674 . Heparin and @entity2690 stimulate lipoprotein-lipase activity and accelerate chylomicron degradation. AIM: To report five @entity1 with @entity656 treated with heparin and @entity2690 . @entity1 AND METHODS: Five @entity1 (4 females and 1 male) seen in the last two years, who suffered @entity656 induced by @entity2298 are reported. Initial blood @entity412 levels were above 1,000 mg/dl (range 1,590-8,690 mg/dl). Besides the usual treatment of @entity656 , heparin and/or @entity2690 were administered intravenously in continuous infusion. Heparin dose was guided by usual parameters of @entity1003 , and @entity2690 dose, by serial determinations of blood @entity413 . @entity39 was demonstrated in 4 patients. RESULTS: Serum @entity412 levels decreased to < 500 mg/dl within 3 days in all cases. No complication of treatment was observed and all @entity1 survived. Early and late complications of @entity788 occurred in one @entity1 . CONCLUSION: Administration of heparin and/or @entity2690 is an efficient alternative to reduce @entity412 levels in @entity1 with @entity656 and @entity2298 .
